This week has been relatively quiet in T2D news. Researchers and writers are undoubtedly on vacation—and rightly so. There was, however, some compelling news about a study of diabetes type 2 as an autoimmune disease.
Instead of only being a metabolic disorder, insulin resistance might be a phenomenon caused by immune cells that affect tissues. A certain antibody that is already in use as treatment for autoimmune diseases could turn out to work on type 2 diabetes as well.
A partial categorization of T2D as an autoimmune disease would also blur the line between T2D and TD1.